Anesth Analg 2008; 107:1832-1839
© 2008 International Anesthesia Research Society
doi: 10.1213/ane.0b013e31818874ee
PEDIATRIC ANESTHESIOLOGY
A Comparison of Dexmedetomidine-Midazolam with Propofol for Maintenance of Anesthesia in Children Undergoing Magnetic Resonance Imaging
Christopher Heard, MBChB, FRCA*,
Frederick Burrows, MD ,
Kristin Johnson, PharmD ,
Prashant Joshi, MD ,
James Houck, MD||, and
Jerrold Lerman, MD, FRCPC, FANZCA¶#
From the *Department of Anesthesiology and Division of Pediatric Critical Care, State University of New York at Buffalo, Women and Childrens Hospital of Buffalo, Buffalo, New York; Department of Anesthesiology, State University of New York at Buffalo, Women and Childrens Hospital of Buffalo, Buffalo, New York; Department of Pharmacy, Women and Childrens Hospital of Buffalo, Buffalo, New York; Division of Pediatric Critical Care, State University of New York at Buffalo, Women and Childrens Hospital of Buffalo, Buffalo, New York; ||Department of Anesthesiology, Women and Childrens Hospital of Buffalo, Buffalo, New York; ¶State University of New York at Buffalo and University of Rochester, Rochester, New York; and #Department of Anesthesiology, Women and Childrens Hospital of Buffalo, Buffalo and Strong Memorial Hospital, Rochester, New York.
Address correspondence to Dr. Christopher Heard, Department of Anesthesiology, Women and Childrens Hospital of Buffalo, 219 Bryant St., Buffalo, NY 14222. Address e-mail to heardop1{at}verizon.net.
Abstract
BACKGROUND: Dexmedetomidine is an 2 agonist that is currently being investigated for its suitability to provide anesthesia for children. We compared the pharmacodynamic responses to dexmedetomidine-midazolam and propofol in children anesthetized with sevoflurane undergoing magnetic resonance imaging (MRI).
METHODS: Forty ASA 1 or 2 children, 1–10 yr of age, were randomized to receive either dexmedetomidine-midazolam or propofol for maintenance of anesthesia for MRI after a sevoflurane induction. Dexmedetomidine was administered as an initial loading dose (1 µg/kg) followed by a continuous infusion (0.5 µg · kg–1 · h–1). Midazolam (0.1 mg/kg) was administered IV when the infusion commenced. Propofol was administered as a continuous infusion (250–300 µg · kg–1 · min–1). Recovery times and hemodynamic responses were recorded by one nurse who was blinded to the treatments.
RESULTS: We found that the times to fully recover and to discharge from the ambulatory unit after dexmedetomidine administration were significantly greater (by 15 min) than those after propofol. Analysis of variance demonstrated that heart rate was slower and systolic blood pressure was greater with dexmedetomidine than propofol. Respiratory indices for the two treatments were similar. During recovery, hemodynamic responses were similar. Cardiorespiratory indices during anesthesia and recovery remained within normal limits for the childrens ages. No adverse events were recorded.
CONCLUSION: Dexmedetomidine-midazolam provides adequate anesthesia for MRI although recovery is prolonged when compared with propofol. Heart rate was slower and systolic blood pressure was greater with dexmedetomidine when compared with propofol. Respiratory indices were similar for the two treatments.
This article has been cited by other articles:

|
 |

|
 |
 
M. Munkwitz
Dexmedetomidine vs Midazolam in Critically Ill Patients: a RCT
AAP Grand Rounds,
July 1, 2009;
22(1):
7 - 7.
[Full Text]
[PDF]
|
 |
|
|